Moderna has initiated the rolling submission process for the biologics license application for its COVID-19 vaccine mRNA-1273.
Moderna announced it is seeking full FDA approval for its COVID-19 vaccine mRNA-1273.
In a statement released on Tuesday, the company said it has initiated the rolling submission process for the biologics license application (BLA) and will continue to submit data from its phase 3 study to support the application for use of the vaccine in individuals 18 years and older. Once the rolling BLA submission process is completed, the FDA will notify Moderna when it is formally accepted for review.1
A Timeline of Key Regulatory and Clinical Updates
Pfizer is applying for full approval of its COVID-19 vaccine, BNT162b2, for use in individuals aged 17 years and older.
This article was originally published on Drug Topics®.
References
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
Integrating pharmacists into PPHTN management for enhanced blood pressure control
December 4th 2023A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.
Read More